https://www.selleckchem.com/pr....oducts/ly3295668.htm
ated transplant outcomes, with a particularly beneficial impact on HLA-mismatched HCT. Adding abatacept to URD HCT was safe, reduced AGVHD, and improved SGFS. These results suggest that abatacept may substantially improve AGVHD-related transplant outcomes, with a particularly beneficial impact on HLA-mismatched HCT.Background SARS-CoV-2 is the new virus, and Streptococcus pneumoniae is one of the most important pathogens affecting humans. However, we do not yet know whether these microorganisms interact. Thus, we aimed to evaluate the
Like
Comment
Share
